British Pharmacopoeia

British Pharmacopoeia CommissionBPB.P.British PharmacopeiaBritish Pharmacopoeia (BP)British pharmacopœia
The British Pharmacopoeia (BP) is the national pharmacopoeia of the United Kingdom.wikipedia
112 Related Articles

Pharmacopoeia

pharmacopeiaLondon Pharmacopoeiapharmacopoeias
The British Pharmacopoeia (BP) is the national pharmacopoeia of the United Kingdom.
As a result, the Medical Act of 1858 ordained that the General Medical Council should publish a book containing a list of medicines and compounds, to be called the British Pharmacopoeia, which would be a substitute throughout Great Britain and Ireland for the separate pharmacopoeias.

Medicines and Healthcare products Regulatory Agency

MHRAMedicines and Healthcare Products Regulatory Agency (MHRA)Medicines Control Agency
The British Pharmacopoeia is an important statutory component in the control of medicines which complements and assists the licensing and inspection processes of the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom.
MHRA hosts and supports a number of expert advisory bodies, including the Commission on Human Medicine which replaced the Committee on the Safety of Medicines in 2005, and the British Pharmacopoeia Commission.

British National Formulary

BNFBNF 75British National Formulary (BNF)
Together with the British National Formulary (BNF), the British Pharmacopoeia defines the UK's pharmaceutical standards.
The British Pharmacopoeia (BP) specifies quality standards for the making of drugs listed in the BNF.

British Approved Name

BANBANM
Under Section 100 of the Medicines Act, the British Pharmacopoeia Commission is also responsible for selecting and devising British Approved Names (BANs )(see #British Approved Names).
A British Approved Name (BAN) is the official, non-proprietary, or generic name given to a pharmaceutical substance, as defined in the British Pharmacopoeia (BP).

British Pharmaceutical Codex

In 1907, the British Pharmacopoeia was supplemented by the British Pharmaceutical Codex, which gave information on drugs and other pharmaceutical substances not included in the BP, and provided standards for these.
The British Pharmaceutical Codex (BPC) was first published in 1907, to supplement the British Pharmacopoeia which although extensive, did not cover all the medicinal items that a pharmacist might require in daily work.

Pharmacopoeia of the People's Republic of China

Chinese medicine pharmacopeiaChinese PharmacopeiaChinese Pharmacopoeia
There are equivalent pharmacopoeia in many other countries, such as U.S. (the United States Pharmacopoeia), Japan (Japanese Pharmacopoeia), and China (Pharmacopoeia of the People's Republic of China), and the World Health Organization maintains The International Pharmacopoeia.

United States Pharmacopeia

USPUnited States PharmacopoeiaU.S. Pharmacopoeia
There are equivalent pharmacopoeia in many other countries, such as U.S. (the United States Pharmacopoeia), Japan (Japanese Pharmacopoeia), and China (Pharmacopoeia of the People's Republic of China), and the World Health Organization maintains The International Pharmacopoeia.

United Kingdom

BritishUKBritain
The British Pharmacopoeia (BP) is the national pharmacopoeia of the United Kingdom.

Drug

drugsagentserum
It is an annually published collection of quality standards for UK medicinal substances.

List of pharmaceutical companies

pharmaceutical firmspharmaceuticals industryPharmaceutical
It is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.

Pharmacy

pharmaciespharmaceutical sciencesdrugstore
It is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.

Drug development

developmentdevelopedclinical development
It is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.

Pharmaceutical manufacturing

manufacturedrug manufacturingmanufacturing
It is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.

Phases of clinical research

phase IIphase IIIphase I
It is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.

Secretary of State for Health and Social Care

Secretary of State for HealthMinister of HealthHealth Secretary
The British Pharmacopoeia is published on behalf of the Health Ministers of the United Kingdom; on the recommendation of the Commission on Human Medicines, in accordance with section 99(6) of the Medicines Act 1968, and notified in draft to the European Commission (EC) in accordance with Directive 98/34/EEC.

Commission on Human Medicines

Medicines CommissionCommission on Human MedicineMedicines Commission UK
The British Pharmacopoeia is published on behalf of the Health Ministers of the United Kingdom; on the recommendation of the Commission on Human Medicines, in accordance with section 99(6) of the Medicines Act 1968, and notified in draft to the European Commission (EC) in accordance with Directive 98/34/EEC.

Medicines Act 1968

Medicines Act
The British Pharmacopoeia is published on behalf of the Health Ministers of the United Kingdom; on the recommendation of the Commission on Human Medicines, in accordance with section 99(6) of the Medicines Act 1968, and notified in draft to the European Commission (EC) in accordance with Directive 98/34/EEC.

European Commission

EU CommissionCommissionEC
The British Pharmacopoeia is published on behalf of the Health Ministers of the United Kingdom; on the recommendation of the Commission on Human Medicines, in accordance with section 99(6) of the Medicines Act 1968, and notified in draft to the European Commission (EC) in accordance with Directive 98/34/EEC.

Monograph

monographsmonographymonographic
The monographs of the European Pharmacopoeia (as amended by Supplements published by the Council of Europe) are reproduced either in the British Pharmacopoeia, or in the associated edition of the British Pharmacopoeia (Veterinary).

European Pharmacopoeia

European PharmacopeiaPh. Eur.EP
The monographs of the European Pharmacopoeia (as amended by Supplements published by the Council of Europe) are reproduced either in the British Pharmacopoeia, or in the associated edition of the British Pharmacopoeia (Veterinary).

Council of Europe

CECoEthe Council of Europe
The monographs of the European Pharmacopoeia (as amended by Supplements published by the Council of Europe) are reproduced either in the British Pharmacopoeia, or in the associated edition of the British Pharmacopoeia (Veterinary).

Patent

patentspatent lawpatented
In the pharmacopoeia, certain drugs and preparations are included regardless of the existence of actual or potential patent rights.

Exclusive right

franchiseexclusive rightsexclusive
In the pharmacopoeia, certain drugs and preparations are included regardless of the existence of actual or potential patent rights.

Letters patent

commissionpatentroyal patent
Where substances are protected by letters patent, their inclusion in the pharmacopoeia neither conveys, nor implies, licence to manufacture.

Henry VIII of England

Henry VIIIKing Henry VIIIKing Henry VIII of England
The regulation of medicinal products by officials in the United Kingdom dates back to the reign of King Henry VIII (1491–1547).